Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Department of Justice
Providers
CVS settles insulin pen fraud allegations with $37.8M payment
CVS Health agreed to pay $37.76 million to settle allegations that it improperly billed federal healthcare programs for insulin pens.
Heather Landi
Dec 2, 2025 3:00pm
Shifting legal challenges have healthcare leaders' attention
Oct 28, 2025 1:36pm
Drug price negotiation program sidesteps latest legal obstacle
Aug 7, 2025 3:00pm
New CMMI model adds prior auth for some services in Medicare
Jun 30, 2025 3:00pm
Trump order aims to revive "most favored nation" policy
May 12, 2025 9:30am
Supreme Court likely to save ACA preventive services task force
Apr 21, 2025 3:40pm
